Amarantus' LymPro Could Be A Game-Changer For Alzheimer's Diagnosis

Apr. 17, 2013 10:35 AM

http://seekingalpha.com/article/1347691-amara...-diagnosis

Quote:

---

"We believe this reinforces the need and desire for early-stage detection, and the potential multi-hundred million dollar opportunity that LymPro represents. We note that LymPro has completed two phase I clinical studies in over 160 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis. These statistics compared favorably to the sensitivity (82-92%) and specificity (95%) of Amyvid, as outlined in the package insert."

---

I'm assuming above data results are from V-1 only...with V-2 data yet tobe revealed...